無料で遊べるライブカジノ Manufacturing Sites

Stable supply system of 3 plants with high production capacity

Towa has total of 14 billion tablets with 3 plants combined, Osaka, Okayama, and Yamagata 無料で遊べるライブカジノ.
We are now constructing a system to boost our manufacturing capacity to 17.5 billion tablets per year to cope with the increasing demand. For the purpose of the stable supply of Towa’s product, the products of oral formulations are separated in 3 portions, and each portion is allocated to 1 of the plants, respectively. On the other hand, injectable are manufactured only at a building with quake-absorbing structure in Yamagata 無料で遊べるライブカジノ. These measures and policies minimize the disaster risk. The 3 plants in compliance with PIC/S GMP achieve high quality and stable supply of products and to support the future with trust.
Osaka 無料で遊べるライブカジノ serves as a tablet technology 無料で遊べるライブカジノ responsible for introducing new products with general formulations, while Okayama 無料で遊べるライブカジノ serves as a mass production technology 無料で遊べるライブカジノ for handling various products including capsules, powders, and granules. Yamagata 無料で遊べるライブカジノ serves as a comprehensive technology 無料で遊べるライブカジノ handling solid formulations, sterile formulations, and their high potent active pharmaceuticals.

3 Plants Overview

  • Osaka 無料で遊べるライブカジノ
    Manufacturing Capacity2.5 billion
    Manufacturing CapabilitiesTablets
  • Okayama 無料で遊べるライブカジノ
    Manufacturing Capacity5 billion
    Manufacturing CapabilitiesTablets, Powder,Granules, Capsules
  • Yamagata 無料で遊べるライブカジノ
    Manufacturing Capacity6.5 billion
    Manufacturing CapabilitiesTablets, Powders, Granules, Capsules, Injections

Injections are manufactured only at a building of quake-absorbing structure in Yamagata 無料で遊べるライブカジノ.

Visiting the highly clean manufacturing environment.

Towa has tour route exclusively designed for visitors at our Plants. Under high-level manufacturing environment, visitors can observe the leading the edge clean manufacturing facilities with their own eyes.
Towa will continue to ensure reliability on the generic industry by opening to medical professionals to see the environment where generic drugs are manufactured.